← Back to patent-cliff list
CAS 13734-41-3
(S)-2-((tert-Butoxycarbonyl)amino)-3-methylbutanoic acid(tert-butoxycarbonyl)-L-valine
Codes: (I)692039-1-a, R-fluoxetine-002
Application context (from source-drug indications)
冠状病毒感染TRV-120027COVID-19TRV-120027Acute decompensated heart failureTRV-120027Kidney diseaseTRV-120027Heart failureTRV-120027分离性焦虑R-fluoxetineAnxietyR-fluoxetineAnxiety disorderR-fluoxetine
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| TRV-120027 | Tier C — Watch / trade | - |
| R-fluoxetine | Tier C — Watch / trade | - |
| Valiltramiprosate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
(S)-2-((tert-Butoxycarbonyl)amino)-3-methylbutanoic acid→Ethoxycarbonyl N-(tert-butoxycarbonyl)-L-valinate→(-)-alpha-Amino-p-hydroxyhydrocinnamic acid→N-(tert-Butoxycarbonyl)-L-valyl-L-tyrosine→Ethoxycarbonyl N-(tert-butoxycarbonyl)-L-valyl-L-tyrosinate→(2S,3S)-alpha-Amino-beta-merthylvaleric acid→N-(tert-Butoxycarbonyl)-L-valyl-L-tyrosyl-L-isoleucine→Benzyl L-histidyl-L-prolyl-D-alaninate hydrochloride→Benzyl L-valyl-L-tyrosyl-L-isoleucyl-L-histidyl-L-prolyl-D-alaninate hydrochloride→N-[(Benzyloxy)carbonyl]-N-methylglycyl-L-arginine→Benzyl N-[(benzyloxy)carbonyl]-N-methylglycyl-L-arginyl-L-valyl-L-tyrosyl-L-isoleucyl-L-histidyl-L-prolyl-D-alaninate hydrochloride→N-Methylglycyl-L-arginyl-L-valyl-L-tyrosyl-L-isoleucyl-L-histidyl-L-prolyl-D-alanine acetate
(S)-2-amino-3-methylbutanoic acid→(tert-butoxycarbonyl)-L-valine→(R)-1-phenylethan-1-amine→tert-butyl ((S)-3-methyl-1-oxo-1-(((R)-1-phenylethyl)amino)butan-2-yl)carbamate→(S)-2-amino-3-methyl-N-((R)-1-phenylethyl)butanamide→(S)-3-methyl-N1-((R)-1-phenylethyl)butane-1,2-diamine→(S)-4-isopropyl-1-((R)-1-phenylethyl)imidazolidin-2-one→(S)-3-acetyl-4-isopropyl-1-((R)-1-phenylethyl)imidazolidin-2-one→(S)-3-((R)-3-hydroxy-3-phenylpropanoyl)-4-isopropyl-1-((R)-1-phenylethyl)imidazolidin-2-one→(R)-3-hydroxy-N-methyl-3-phenylpropanamide→(R)-3-(methylamino)-1-phenylpropan-1-ol→1-fluoro-4-(trifluoromethyl)benzene→R-fluoxetine
#1→(tert-butoxycarbonyl)-L-valine→2,5-dioxopyrrolidin-1-yl L-valinate→3-aminopropane-1-sulfonic acid
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.